New River names new VP of sales

Share this article:
New River Pharmaceuticals named James Shaffer as VP of sales and marketing to oversee the anticipated launch of the company's attention deficit-hyperactivity disorder (ADHD) drug Vyvanse.
Shaffer joins New River from Prestwick Pharmaceuticals. Shaffer served as senior director, commercial operations at Prestwick since 2004. Prior to that, he worked at Intermune as national sales director.

New River will co-market Vyvanse along with Shire. Vyvanse is expected to follow in the footsteps of Shire's ADHD market-leading Adderall XR but is formulated to be harder to abuse.

Share this article:
You must be a registered member of MMM to post a comment.
close

Next Article in Pharmaceutical

 

Did you miss January's Top 40 Healthcare Transformers issue? Read how these inventors, strategists, entrepreneurs and wonks are challenging, disrupting and otherwise transforming the healthcare business. And join us April 30 to honor them at the Transforming Healthcare Dinner. Click here.